Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase III Evaluation Of Fetal Fibronectin In A High Risk Asymptomatic Population For The Prediction Of Spontaneous Preterm Birth

NCT01955148 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT01955148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01955148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase III Evaluation Of Fetal Fibronectin In A High Risk Asymptomatic Population For The Prediction Of Spontaneous Preterm Birth
Lead sponsor
Hologic, Inc.
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
September 30, 2016
Enrollment
1,210 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

pre-term birth